The DOI matches its OpenAlex record; 45 of the 45 references it cites were found in a registry or an index.
Statin Therapy: Review of Safety and Potential Side Effects.
Open accessAbstract
BACKGROUND: Hydroxymethyl glutaryl coenzyme A reductase inhibitors, commonly called statins, are some of the most commonly prescribed medications worldwide. Evidence suggests that statin therapy has significant mortality and morbidity benefit for both primary and secondary prevention from cardiovascular disease. Nonetheless, concern has been expressed regarding the adverse effects of long term statin use. The purpose of this article was to review the current medical literature regarding the safety of statins. METHODS: Major trials and review articles on the safety of statins were identified in a search of the MEDLINE database from 1980 to 2016, which was limited to English articles. RESULTS: Myalgia is the most common side effect of statin use, with documented rates from 1-10%. Rhabdomyolysis is the most serious adverse effect from statin use, though it occurs quite rarely (less than 0.1%). The most common risk factors for statin-related myopathy include hypothyroidism, polypharmacy and alcohol abuse. Derangement in liver function tests is common, affecting up to 1% of patients; however, the clinical significance of this is unknown. Some statin drugs are potentially diabetogenic and the risk appears to increase in those patients on higher doses. Pitavastatin has not been associated with increased risk of diabetes. Statins have not been proven to increase the risk of malignancy, dementia, mood disorders or acute interstitial nephritis. However, statins do have multiple drug interactions, primarily those which interact with the cytochrome p450 enzyme group. CONCLUSIONS: Overall, statin drugs appear to be safe for use in the vast majority of patients. However, patients with multiple medical co-morbidities are at increased risk of adverse effects from long-term statin use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043545 · Cited by 2,614
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Fellström, B. C., Jardine, A. G., Schmieder, R. E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.-W., Chevaile, A., Cobbe, S. M., Grönhagen-Riska, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810177 · Cited by 2,036
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Stroes, E. S., Thompson, P. D., Corsini, A., Vladutiu, G. D., Raal, F. J., Ray, K. K., Roden, M., Stein, E., Tokgözoğlu, L., Nordestgaard, B. G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv043 · Cited by 1,443
Preiss, D. (2011) · JAMA · doi:10.1001/jama.2011.860 · Cited by 1,390
Statins for Improving Renal Outcomes: A Meta-Analysis
Sandhu, S., Wiebe, N., Fried, L. F., & Tonelli, M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010012 · Cited by 478
Risks Associated With Statin Therapy: A Systematic Overview of Randomized Clinical Trials
Kashani, A., Phillips, C. O., Foody, J. M., Wang, Y., Mangalmurti, S., Ko, D. T., & Krumholz, H. M. (2006) · Circulation · doi:10.1161/circulationaha.106.624890 · Cited by 474
Long-term follow-up of the West of Scotland Coronary Prevention Study
Ford, I., Murray, H., Packard, C. J., Shepherd, J., Macfarlane, P. W., & Cobbe, S. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065994 · Cited by 416
Bianchi, S., Bigazzi, R., Caiazza, A., & Campese, V. M. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50140 · Cited by 332
Cederberg, H., Stančáková, A., Yaluri, N., Modi, S., Kuusisto, J., & Laakso, M. (2015) · Diabetologia · doi:10.1007/s00125-015-3528-5 · Cited by 316
Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
Navarese, E. P., Buffon, A., Andreotti, F., Kozinski, M., Welton, N., Fabiszak, T., Caputo, S., Grzesk, G., Kubica, A., Swiatkiewicz, I., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.037 · Cited by 308
Statins and risk of polyneuropathy: A case-control study
Gaist, D., Jeppesen, U., Andersen, M., García Rodríguez, L. A., Hallas, J., & Sindrup, S. H. (2002) · Neurology · doi:10.1212/wnl.58.9.1333 · Cited by 270
Dormuth, C. R., Hemmelgarn, B. R., Paterson, J. M., James, M. T., Teare, G. F., Raymond, C. B., Lafrance, J.-P., Levy, A., Garg, A. X., Ernst, P., et al. (2013) · BMJ · doi:10.1136/bmj.f880 · Cited by 246
Do Statins Impair Cognition? A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Ott, B. R., Daiello, L. A., Dahabreh, I. J., Springate, B. A., Bixby, K., Murali, M., & Trikalinos, T. A. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-014-3115-3 · Cited by 239
Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network
Russo, M. W., Hoofnagle, J. H., Gu, J., Fontana, R. J., Barnhart, H., Kleiner, D. E., Chalasani, N., & Bonkovsky, H. L. (2014) · Hepatology · doi:10.1002/hep.27157 · Cited by 222
Baigent, C., Landray, M., Leaper, C., Altmann, P., Armitage, J., Baxter, A., Cairns, H. S., Collins, R., Foley, R. N., Frighi, V., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.11.015 · Cited by 210
Intolerance to Statins: Mechanisms and Management
Bitzur, R., Cohen, H., Kamari, Y., & Harats, D. (2013) · Diabetes Care · doi:10.2337/dcs13-2038 · Cited by 179
de Zeeuw, D., Anzalone, D. A., Cain, V. A., Cressman, M. D., Heerspink, H. J. L., Molitoris, B. A., Monyak, J. T., Parving, H.-H., Remuzzi, G., Sowers, J. R., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70246-3 · Cited by 167
Saku, K., Zhang, B., Noda, K., & The PATROL Trial Investigators (2011) · Circulation Journal · doi:10.1253/circj.cj-10-1281 · Cited by 131
Odden, M. C., Pletcher, M. J., Coxson, P. G., Thekkethala, D., Guzman, D., Heller, D. J., Goldman, L., & Bibbins-Domingo, K. B. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1430 · Cited by 129
Lipid-Lowering Drugs and the Risk of Depression and Suicidal Behavior
Yang, C., Jick, S. S., & Jick, H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.16.1926 · Cited by 117
Sasaki, J. D., Ikeda, Y., Kuribayashi, T., Kajiwara, K., Biro, S., Yamamoto, K., Ageta, M., Kobori, S., Saikawa, T., Otonari, T., et al. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.05.017 · Cited by 110
Statin use and all-cancer survival: prospective results from the Women’s Health Initiative
Wang, A., Aragaki, A. K., Tang, J. Y., Kurian, A. W., Manson, J. E., Chlebowski, R. T., Simon, M. S., Desai, P. M., Wassertheil-Smoller, S. W., Liu, S., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.149 · Cited by 102
Yokote, K., Bujo, H., Hanaoka, H., Shinomiya, M., Mikami, K., Miyashita, Y., Nishikawa, T., Kodama, T., Tada, N., & Saitō, Y. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.008 · Cited by 100
Thobari, J. A., Brantsma, A. H., Gansevoort, R. T., Visser, S. T., Asselbergs, F. W., van Gilst, W. H., de Jong, P. E., den Berg, L. T. W. D. J.-V., & on behalf of PREVEND study group (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl244 · Cited by 94
Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink
McGlynn, K. A., Hagberg, K. W., Chen, J., Graubard, B. I., London, W. T., Jick, S. S., & Sahasrabuddhe, V. V. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv009 · Cited by 76
García‐Rodríguez, L. A., Massó-González, E. L., Wallander, M.-A. A., & Johansson, S. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1603 · Cited by 65
Brown, W. V. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328319baba · Cited by 61
Statin Treatment, New-Onset Diabetes, and Other Adverse Effects: A Systematic Review
Bang, C. N., & Okin, P. M. (2014) · Current Cardiology Reports · doi:10.1007/s11886-013-0461-4 · Cited by 57
Statins and the risk of interstitial lung disease: a cohort study
Saad, N., Camus, P., Suissa, S., & Ernst, P. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-201823 · Cited by 52
Ruggenenti, P. L., Perna, A., Tonelli, M. A., Loriga, G., Motterlini, N., Rubis, N., Ledda, F., Rota, S., Satta, A. E., Granata, A. R. M., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03380410 · Cited by 48
Yokote, K., Shimano, H., Urashima, M., & Teramoto, T. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.47 · Cited by 45
Bangalore, S., Fayyad, R. S., Hovingh, G. K., Laskey, R. E., Vogt, L., DeMicco, D. A., & Waters, D. D. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.03.046 · Cited by 42
Pradelli, D., Soranna, D., Zambon, A., Catapano, A. L., Mancia, G., Vecchia, C. L., & Corrao, G. (2015) · Cancer Medicine · doi:10.1002/cam4.411 · Cited by 35
Statin Myopathy: A Lipid Clinic Experience on the Tolerability of Statin Rechallenge
Fung, E. C., & Crook, M. A. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00267.x · Cited by 34
Castro, M. R., Simon, G., Cha, S. S., Yawn, B. P., Melton, L. J., & Caraballo, P. J. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3583-0 · Cited by 34
Huang, W.-C., Lin, T.-W., Chiou, K.-R., Cheng, C., Kuo, F. Y., Chiang, C., Yang, J.-S., Lin, K., Hsiao, S.-H., Yeh, T.-C., et al. (2013) · Europe PMC (PubMed Central) · Cited by 17
Jhuo, S., Tsai, W., Lin, T., Voon, W., Lai, W., & Sheu, S. (2016) · Europe PMC (PubMed Central) · doi:10.6515/acs20150204c · Cited by 10
Cited by
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 302
Agolino, G., Pino, A., Vaccalluzzo, A., Cristofolini, M., Solieri, L., Caggia, C., & Randazzo, C. L. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106357 · Cited by 99
The impact of glucocorticoids and statins on sleep quality
Szmyd, B., Rogut, M., Białasiewicz, P., & Gabryelska, A. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101380 · Cited by 66
Morató, X., Pytel, V., Jofresa, S., Ruiz, A., & Boada, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169305 · Cited by 53
“Statins are among the most frequently prescribed medications [209].”
BackgroundInclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
Wołowiec, Ł., Osiak, J., Wołowiec, A., Wijata, A., Grześk, E., Kozakiewicz, M., Banach, J., Nowaczyk, A., Nowaczyk, J., & Grześk, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020323 · Cited by 43
Metadata
- Authors
- Ramkumar, S., Raghunath, A., & Raghunath, S.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2016-11-01
- Volume
- 32
- Issue
- 6
- Pages
- 631-639
- OpenAlex
- W2559896499
- Cited by
- 358
- References
- 45
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.